A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
Not yet recruiting · NCT07078955 · Registry updated 2025-10-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease | Conjunctival Diseases, conjunctivitis, corneal disorder, dry eye syndrome, eye disorder, keratitis, keratoconjunctivitis, lacrimal apparatus disorder | Not yet recruiting | Phase 2 | 2025-10-20 | NCT07078955 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BRIM Biotechnology Inc. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| New Taipei Municipal TuCheng Hospital | New Taipei City | Taiwan | 2 |